Condensed Consolidating Balance Sheet |
The following table presents the condensed consolidating balance
sheet information as of September 30, 2015:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(Amounts in millions)
|
|
Parent
Guarantor |
|
|
Issuer |
|
|
All Other
Subsidiaries |
|
|
Eliminations |
|
|
Consolidated |
|
Assets
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Investments:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fixed maturity securities available-for-sale, at fair value
|
|
$ |
— |
|
|
$ |
150 |
|
|
$ |
60,901 |
|
|
$ |
(200 |
) |
|
$ |
60,851 |
|
Equity securities available-for-sale, at fair value
|
|
|
— |
|
|
|
— |
|
|
|
273 |
|
|
|
— |
|
|
|
273 |
|
Commercial mortgage loans
|
|
|
— |
|
|
|
— |
|
|
|
6,133 |
|
|
|
— |
|
|
|
6,133 |
|
Restricted commercial mortgage loans related to securitization
entities
|
|
|
— |
|
|
|
— |
|
|
|
175 |
|
|
|
— |
|
|
|
175 |
|
Policy loans
|
|
|
— |
|
|
|
— |
|
|
|
1,567 |
|
|
|
— |
|
|
|
1,567 |
|
Other invested assets
|
|
|
— |
|
|
|
124 |
|
|
|
2,652 |
|
|
|
(3 |
) |
|
|
2,773 |
|
Restricted other invested assets related to securitization
entities, at fair value
|
|
|
— |
|
|
|
— |
|
|
|
412 |
|
|
|
— |
|
|
|
412 |
|
Investments in subsidiaries
|
|
|
13,563 |
|
|
|
13,610 |
|
|
|
— |
|
|
|
(27,173 |
) |
|
|
— |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total investments
|
|
|
13,563 |
|
|
|
13,884 |
|
|
|
72,113 |
|
|
|
(27,376 |
) |
|
|
72,184 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash and cash equivalents
|
|
|
— |
|
|
|
734 |
|
|
|
2,932 |
|
|
|
— |
|
|
|
3,666 |
|
Accrued investment income
|
|
|
— |
|
|
|
— |
|
|
|
685 |
|
|
|
— |
|
|
|
685 |
|
Deferred acquisition costs
|
|
|
— |
|
|
|
— |
|
|
|
4,437 |
|
|
|
— |
|
|
|
4,437 |
|
Intangible assets
|
|
|
— |
|
|
|
— |
|
|
|
284 |
|
|
|
— |
|
|
|
284 |
|
Goodwill
|
|
|
— |
|
|
|
— |
|
|
|
14 |
|
|
|
— |
|
|
|
14 |
|
Reinsurance recoverable
|
|
|
— |
|
|
|
— |
|
|
|
17,276 |
|
|
|
— |
|
|
|
17,276 |
|
Other assets
|
|
|
2 |
|
|
|
216 |
|
|
|
361 |
|
|
|
(2 |
) |
|
|
577 |
|
Intercompany notes receivable
|
|
|
2 |
|
|
|
291 |
|
|
|
399 |
|
|
|
(692 |
) |
|
|
— |
|
Separate account assets
|
|
|
— |
|
|
|
— |
|
|
|
7,893 |
|
|
|
— |
|
|
|
7,893 |
|
Assets held for sale related to discontinued operations
|
|
|
— |
|
|
|
— |
|
|
|
1,206 |
|
|
|
— |
|
|
|
1,206 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total assets
|
|
$ |
13,567 |
|
|
$ |
15,125 |
|
|
$ |
107,600 |
|
|
$ |
(28,070 |
) |
|
$ |
108,222 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Liabilities and stockholders’ equity
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Liabilities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Future policy benefits
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
36,472 |
|
|
$ |
— |
|
|
$ |
36,472 |
|
Policyholder account balances
|
|
|
— |
|
|
|
— |
|
|
|
26,000 |
|
|
|
— |
|
|
|
26,000 |
|
Liability for policy and contract claims
|
|
|
— |
|
|
|
— |
|
|
|
8,065 |
|
|
|
— |
|
|
|
8,065 |
|
Unearned premiums
|
|
|
— |
|
|
|
— |
|
|
|
3,340 |
|
|
|
— |
|
|
|
3,340 |
|
Other liabilities
|
|
|
5 |
|
|
|
260 |
|
|
|
2,982 |
|
|
|
(6 |
) |
|
|
3,241 |
|
Intercompany notes payable
|
|
|
— |
|
|
|
602 |
|
|
|
290 |
|
|
|
(892 |
) |
|
|
— |
|
Borrowings related to securitization entities
|
|
|
— |
|
|
|
— |
|
|
|
188 |
|
|
|
— |
|
|
|
188 |
|
Non-recourse funding obligations
|
|
|
— |
|
|
|
— |
|
|
|
1,951 |
|
|
|
— |
|
|
|
1,951 |
|
Long-term borrowings
|
|
|
— |
|
|
|
4,100 |
|
|
|
501 |
|
|
|
— |
|
|
|
4,601 |
|
Deferred tax liability
|
|
|
(23 |
) |
|
|
(1,077 |
) |
|
|
1,301 |
|
|
|
— |
|
|
|
201 |
|
Separate account liabilities
|
|
|
— |
|
|
|
— |
|
|
|
7,893 |
|
|
|
— |
|
|
|
7,893 |
|
Liabilities held for sale related to discontinued operations
|
|
|
6 |
|
|
|
— |
|
|
|
848 |
|
|
|
— |
|
|
|
854 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total liabilities
|
|
|
(12 |
) |
|
|
3,885 |
|
|
|
89,831 |
|
|
|
(898 |
) |
|
|
92,806 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stockholders’ equity:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common stock
|
|
|
1 |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
1 |
|
Additional paid-in capital
|
|
|
11,944 |
|
|
|
9,098 |
|
|
|
16,956 |
|
|
|
(26,054 |
) |
|
|
11,944 |
|
Accumulated other comprehensive income (loss)
|
|
|
3,478 |
|
|
|
3,560 |
|
|
|
3,498 |
|
|
|
(7,058 |
) |
|
|
3,478 |
|
Retained earnings
|
|
|
856 |
|
|
|
(1,418 |
) |
|
|
(4,827 |
) |
|
|
6,245 |
|
|
|
856 |
|
Treasury stock, at cost
|
|
|
(2,700 |
) |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
(2,700 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Genworth Financial, Inc.’s stockholders’
equity
|
|
|
13,579 |
|
|
|
11,240 |
|
|
|
15,627 |
|
|
|
(26,867 |
) |
|
|
13,579 |
|
Noncontrolling interests
|
|
|
— |
|
|
|
— |
|
|
|
2,142 |
|
|
|
(305 |
) |
|
|
1,837 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total stockholders’ equity
|
|
|
13,579 |
|
|
|
11,240 |
|
|
|
17,769 |
|
|
|
(27,172 |
) |
|
|
15,416 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total liabilities and stockholders’ equity
|
|
$ |
13,567 |
|
|
$ |
15,125 |
|
|
$ |
107,600 |
|
|
$ |
(28,070 |
) |
|
$ |
108,222 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The following table presents the condensed consolidating balance
sheet information as of December 31, 2014:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(Amounts in millions)
|
|
Parent
Guarantor |
|
|
Issuer |
|
|
All Other
Subsidiaries |
|
|
Eliminations |
|
|
Consolidated |
|
Assets
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Investments:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fixed maturity securities available-for-sale, at fair value
|
|
$ |
— |
|
|
$ |
150 |
|
|
$ |
61,326 |
|
|
$ |
(200 |
) |
|
$ |
61,276 |
|
Equity securities available-for-sale, at fair value
|
|
|
— |
|
|
|
— |
|
|
|
275 |
|
|
|
— |
|
|
|
275 |
|
Commercial mortgage loans
|
|
|
— |
|
|
|
— |
|
|
|
6,100 |
|
|
|
— |
|
|
|
6,100 |
|
Restricted commercial mortgage loans related to securitization
entities
|
|
|
— |
|
|
|
— |
|
|
|
201 |
|
|
|
— |
|
|
|
201 |
|
Policy loans
|
|
|
— |
|
|
|
— |
|
|
|
1,501 |
|
|
|
— |
|
|
|
1,501 |
|
Other invested assets
|
|
|
— |
|
|
|
14 |
|
|
|
2,235 |
|
|
|
(5 |
) |
|
|
2,244 |
|
Restricted other invested assets related to securitization
entities, at fair value
|
|
|
— |
|
|
|
— |
|
|
|
411 |
|
|
|
— |
|
|
|
411 |
|
Investments in subsidiaries
|
|
|
14,895 |
|
|
|
15,003 |
|
|
|
— |
|
|
|
(29,898 |
) |
|
|
— |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total investments
|
|
|
14,895 |
|
|
|
15,167 |
|
|
|
72,049 |
|
|
|
(30,103 |
) |
|
|
72,008 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash and cash equivalents
|
|
|
— |
|
|
|
953 |
|
|
|
3,763 |
|
|
|
— |
|
|
|
4,716 |
|
Accrued investment income
|
|
|
— |
|
|
|
— |
|
|
|
668 |
|
|
|
(4 |
) |
|
|
664 |
|
Deferred acquisition costs
|
|
|
— |
|
|
|
— |
|
|
|
4,849 |
|
|
|
— |
|
|
|
4,849 |
|
Intangible assets
|
|
|
— |
|
|
|
— |
|
|
|
250 |
|
|
|
— |
|
|
|
250 |
|
Goodwill
|
|
|
— |
|
|
|
— |
|
|
|
16 |
|
|
|
— |
|
|
|
16 |
|
Reinsurance recoverable
|
|
|
— |
|
|
|
— |
|
|
|
17,314 |
|
|
|
— |
|
|
|
17,314 |
|
Other assets
|
|
|
2 |
|
|
|
207 |
|
|
|
316 |
|
|
|
(1 |
) |
|
|
524 |
|
Intercompany notes receivable
|
|
|
9 |
|
|
|
267 |
|
|
|
395 |
|
|
|
(671 |
) |
|
|
— |
|
Separate account assets
|
|
|
— |
|
|
|
— |
|
|
|
9,208 |
|
|
|
— |
|
|
|
9,208 |
|
Assets held for sale related to discontinued operations
|
|
|
— |
|
|
|
— |
|
|
|
1,809 |
|
|
|
— |
|
|
|
1,809 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total assets
|
|
$ |
14,906 |
|
|
$ |
16,594 |
|
|
$ |
110,637 |
|
|
$ |
(30,779 |
) |
|
$ |
111,358 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Liabilities and stockholders’ equity
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Liabilities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Future policy benefits
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
35,915 |
|
|
$ |
— |
|
|
$ |
35,915 |
|
Policyholder account balances
|
|
|
— |
|
|
|
— |
|
|
|
26,032 |
|
|
|
— |
|
|
|
26,032 |
|
Liability for policy and contract claims
|
|
|
— |
|
|
|
— |
|
|
|
7,937 |
|
|
|
— |
|
|
|
7,937 |
|
Unearned premiums
|
|
|
— |
|
|
|
— |
|
|
|
3,547 |
|
|
|
— |
|
|
|
3,547 |
|
Other liabilities
|
|
|
3 |
|
|
|
251 |
|
|
|
3,039 |
|
|
|
(11 |
) |
|
|
3,282 |
|
Intercompany notes payable
|
|
|
— |
|
|
|
604 |
|
|
|
267 |
|
|
|
(871 |
) |
|
|
— |
|
Borrowings related to securitization entities
|
|
|
— |
|
|
|
— |
|
|
|
219 |
|
|
|
— |
|
|
|
219 |
|
Non-recourse funding obligations
|
|
|
— |
|
|
|
— |
|
|
|
1,996 |
|
|
|
— |
|
|
|
1,996 |
|
Long-term borrowings
|
|
|
— |
|
|
|
4,151 |
|
|
|
488 |
|
|
|
— |
|
|
|
4,639 |
|
Deferred tax liability
|
|
|
(20 |
) |
|
|
(970 |
) |
|
|
1,848 |
|
|
|
— |
|
|
|
858 |
|
Separate account liabilities
|
|
|
— |
|
|
|
— |
|
|
|
9,208 |
|
|
|
— |
|
|
|
9,208 |
|
Liabilities held for sale related to discontinued operations
|
|
|
— |
|
|
|
— |
|
|
|
928 |
|
|
|
— |
|
|
|
928 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total liabilities
|
|
|
(17 |
) |
|
|
4,036 |
|
|
|
91,424 |
|
|
|
(882 |
) |
|
|
94,561 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stockholders’ equity:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common stock
|
|
|
1 |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
1 |
|
Additional paid-in capital
|
|
|
11,997 |
|
|
|
9,162 |
|
|
|
17,080 |
|
|
|
(26,242 |
) |
|
|
11,997 |
|
Accumulated other comprehensive income (loss)
|
|
|
4,446 |
|
|
|
4,449 |
|
|
|
4,459 |
|
|
|
(8,908 |
) |
|
|
4,446 |
|
Retained earnings
|
|
|
1,179 |
|
|
|
(1,053 |
) |
|
|
(4,205 |
) |
|
|
5,258 |
|
|
|
1,179 |
|
Treasury stock, at cost
|
|
|
(2,700 |
) |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
(2,700 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Genworth Financial, Inc.’s stockholders’
equity
|
|
|
14,923 |
|
|
|
12,558 |
|
|
|
17,334 |
|
|
|
(29,892 |
) |
|
|
14,923 |
|
Noncontrolling interests
|
|
|
— |
|
|
|
— |
|
|
|
1,879 |
|
|
|
(5 |
) |
|
|
1,874 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total stockholders’ equity
|
|
|
14,923 |
|
|
|
12,558 |
|
|
|
19,213 |
|
|
|
(29,897 |
) |
|
|
16,797 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total liabilities and stockholders’ equity
|
|
$ |
14,906 |
|
|
$ |
16,594 |
|
|
$ |
110,637 |
|
|
$ |
(30,779 |
) |
|
$ |
111,358 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Condensed Consolidating Income Statement |
The following table presents the condensed consolidating income
statement information for the three months ended September 30,
2015:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(Amounts in millions)
|
|
Parent
Guarantor |
|
|
Issuer |
|
|
All Other
Subsidiaries |
|
|
Eliminations |
|
|
Consolidated |
|
Revenues:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Premiums
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
1,145 |
|
|
$ |
— |
|
|
$ |
1,145 |
|
Net investment income
|
|
|
(1 |
) |
|
|
— |
|
|
|
788 |
|
|
|
(4 |
) |
|
|
783 |
|
Net investment gains (losses)
|
|
|
— |
|
|
|
21 |
|
|
|
(72 |
) |
|
|
— |
|
|
|
(51 |
) |
Insurance and investment product fees and other
|
|
|
— |
|
|
|
(10 |
) |
|
|
233 |
|
|
|
— |
|
|
|
223 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total revenues
|
|
|
(1 |
) |
|
|
11 |
|
|
|
2,094 |
|
|
|
(4 |
) |
|
|
2,100 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Benefits and expenses:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Benefits and other changes in policy reserves
|
|
|
— |
|
|
|
— |
|
|
|
1,290 |
|
|
|
— |
|
|
|
1,290 |
|
Interest credited
|
|
|
— |
|
|
|
— |
|
|
|
179 |
|
|
|
— |
|
|
|
179 |
|
Acquisition and operating expenses, net of deferrals
|
|
|
9 |
|
|
|
1 |
|
|
|
304 |
|
|
|
— |
|
|
|
314 |
|
Amortization of deferred acquisition costs and intangibles
|
|
|
— |
|
|
|
— |
|
|
|
563 |
|
|
|
— |
|
|
|
563 |
|
Interest expense
|
|
|
— |
|
|
|
77 |
|
|
|
32 |
|
|
|
(4 |
) |
|
|
105 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total benefits and expenses
|
|
|
9 |
|
|
|
78 |
|
|
|
2,368 |
|
|
|
(4 |
) |
|
|
2,451 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income (loss) from continuing operations before income taxes and
equity in income of subsidiaries
|
|
|
(10 |
) |
|
|
(67 |
) |
|
|
(274 |
) |
|
|
— |
|
|
|
(351 |
) |
Provision (benefit) for income taxes
|
|
|
(40 |
) |
|
|
21 |
|
|
|
(115 |
) |
|
|
— |
|
|
|
(134 |
) |
Equity in income (loss) of subsidiaries
|
|
|
(314 |
) |
|
|
(270 |
) |
|
|
— |
|
|
|
584 |
|
|
|
— |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income (loss) from continuing operations
|
|
|
(284 |
) |
|
|
(358 |
) |
|
|
(159 |
) |
|
|
584 |
|
|
|
(217 |
) |
Income (loss) from discontinued operations, net of taxes
|
|
|
— |
|
|
|
— |
|
|
|
(21 |
) |
|
|
— |
|
|
|
(21 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income (loss)
|
|
|
(284 |
) |
|
|
(358 |
) |
|
|
(180 |
) |
|
|
584 |
|
|
|
(238 |
) |
Less: net income attributable to noncontrolling interests
|
|
|
— |
|
|
|
— |
|
|
|
46 |
|
|
|
— |
|
|
|
46 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income (loss) available to Genworth Financial, Inc.’s
common stockholders
|
|
$ |
(284 |
) |
|
$ |
(358 |
) |
|
$ |
(226 |
) |
|
$ |
584 |
|
|
$ |
(284 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The following table presents the condensed consolidating income
statement information for the three months ended September 30,
2014:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(Amounts in millions)
|
|
Parent
Guarantor |
|
|
Issuer |
|
|
All Other
Subsidiaries |
|
|
Eliminations |
|
|
Consolidated |
|
Revenues:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Premiums
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
1,210 |
|
|
$ |
— |
|
|
$ |
1,210 |
|
Net investment income
|
|
|
(1 |
) |
|
|
— |
|
|
|
783 |
|
|
|
(4 |
) |
|
|
778 |
|
Net investment gains (losses)
|
|
|
— |
|
|
|
9 |
|
|
|
(36 |
) |
|
|
— |
|
|
|
(27 |
) |
Insurance and investment product fees and other
|
|
|
— |
|
|
|
— |
|
|
|
229 |
|
|
|
— |
|
|
|
229 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total revenues
|
|
|
(1 |
) |
|
|
9 |
|
|
|
2,186 |
|
|
|
(4 |
) |
|
|
2,190 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Benefits and expenses:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Benefits and other changes in policy reserves
|
|
|
— |
|
|
|
— |
|
|
|
1,934 |
|
|
|
— |
|
|
|
1,934 |
|
Interest credited
|
|
|
— |
|
|
|
— |
|
|
|
185 |
|
|
|
— |
|
|
|
185 |
|
Acquisition and operating expenses, net of deferrals
|
|
|
5 |
|
|
|
— |
|
|
|
279 |
|
|
|
— |
|
|
|
284 |
|
Amortization of deferred acquisition costs and intangibles
|
|
|
— |
|
|
|
— |
|
|
|
113 |
|
|
|
— |
|
|
|
113 |
|
Goodwill impairment
|
|
|
— |
|
|
|
— |
|
|
|
550 |
|
|
|
— |
|
|
|
550 |
|
Interest expense
|
|
|
— |
|
|
|
77 |
|
|
|
31 |
|
|
|
(4 |
) |
|
|
104 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total benefits and expenses
|
|
|
5 |
|
|
|
77 |
|
|
|
3,092 |
|
|
|
(4 |
) |
|
|
3,170 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income (loss) from continuing operations before income taxes and
equity in income (loss) of subsidiaries
|
|
|
(6 |
) |
|
|
(68 |
) |
|
|
(906 |
) |
|
|
— |
|
|
|
(980 |
) |
Provision (benefit) for income taxes
|
|
|
8 |
|
|
|
(16 |
) |
|
|
(179 |
) |
|
|
— |
|
|
|
(187 |
) |
Equity in income (loss) of subsidiaries
|
|
|
(830 |
) |
|
|
(785 |
) |
|
|
— |
|
|
|
1,615 |
|
|
|
— |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income (loss) from continuing operations
|
|
|
(844 |
) |
|
|
(837 |
) |
|
|
(727 |
) |
|
|
1,615 |
|
|
|
(793 |
) |
Income (loss) from discontinued operations, net of taxes
|
|
|
— |
|
|
|
— |
|
|
|
6 |
|
|
|
— |
|
|
|
6 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income (loss)
|
|
|
(844 |
) |
|
|
(837 |
) |
|
|
(721 |
) |
|
|
1,615 |
|
|
|
(787 |
) |
Less: net income attributable to noncontrolling interests
|
|
|
— |
|
|
|
— |
|
|
|
57 |
|
|
|
— |
|
|
|
57 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income (loss) available to Genworth Financial, Inc.’s
common stockholders
|
|
$ |
(844 |
) |
|
$ |
(837 |
) |
|
$ |
(778 |
) |
|
$ |
1,615 |
|
|
$ |
(844 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The following table presents the condensed consolidating income
statement information for the nine months ended September 30,
2015:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(Amounts in millions)
|
|
Parent
Guarantor |
|
|
Issuer |
|
|
All Other
Subsidiaries |
|
|
Eliminations |
|
|
Consolidated |
|
Revenues:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Premiums
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
3,422 |
|
|
$ |
— |
|
|
$ |
3,422 |
|
Net investment income
|
|
|
(2 |
) |
|
|
1 |
|
|
|
2,369 |
|
|
|
(11 |
) |
|
|
2,357 |
|
Net investment gains (losses)
|
|
|
— |
|
|
|
37 |
|
|
|
(96 |
) |
|
|
— |
|
|
|
(59 |
) |
Insurance and investment product fees and other
|
|
|
— |
|
|
|
(30 |
) |
|
|
703 |
|
|
|
(1 |
) |
|
|
672 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total revenues
|
|
|
(2 |
) |
|
|
8 |
|
|
|
6,398 |
|
|
|
(12 |
) |
|
|
6,392 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Benefits and expenses:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Benefits and other changes in policy reserves
|
|
|
— |
|
|
|
— |
|
|
|
3,714 |
|
|
|
— |
|
|
|
3,714 |
|
Interest credited
|
|
|
— |
|
|
|
— |
|
|
|
540 |
|
|
|
— |
|
|
|
540 |
|
Acquisition and operating expenses, net of deferrals
|
|
|
23 |
|
|
|
2 |
|
|
|
851 |
|
|
|
— |
|
|
|
876 |
|
Amortization of deferred acquisition costs and intangibles
|
|
|
— |
|
|
|
— |
|
|
|
759 |
|
|
|
— |
|
|
|
759 |
|
Interest expense
|
|
|
— |
|
|
|
231 |
|
|
|
96 |
|
|
|
(12 |
) |
|
|
315 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total benefits and expenses
|
|
|
23 |
|
|
|
233 |
|
|
|
5,960 |
|
|
|
(12 |
) |
|
|
6,204 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income (loss) from continuing operations before income taxes and
equity in income of subsidiaries
|
|
|
(25 |
) |
|
|
(225 |
) |
|
|
438 |
|
|
|
— |
|
|
|
188 |
|
Provision (benefit) for income taxes
|
|
|
(7 |
) |
|
|
(81 |
) |
|
|
115 |
|
|
|
— |
|
|
|
27 |
|
Equity in income (loss) of subsidiaries
|
|
|
(299 |
) |
|
|
(319 |
) |
|
|
— |
|
|
|
618 |
|
|
|
— |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income (loss) from continuing operations
|
|
|
(317 |
) |
|
|
(463 |
) |
|
|
323 |
|
|
|
618 |
|
|
|
161 |
|
Income (loss) from discontinued operations, net of taxes
|
|
|
(6 |
) |
|
|
— |
|
|
|
(328 |
) |
|
|
— |
|
|
|
(334 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income (loss)
|
|
|
(323 |
) |
|
|
(463 |
) |
|
|
(5 |
) |
|
|
618 |
|
|
|
(173 |
) |
Less: net income attributable to noncontrolling interests
|
|
|
— |
|
|
|
— |
|
|
|
150 |
|
|
|
— |
|
|
|
150 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income (loss) available to Genworth Financial, Inc.’s
common stockholders
|
|
$ |
(323 |
) |
|
$ |
(463 |
) |
|
$ |
(155 |
) |
|
$ |
618 |
|
|
$ |
(323 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The following table presents the condensed consolidating income
statement information for the nine months ended September 30,
2014:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(Amounts in millions)
|
|
Parent
Guarantor |
|
|
Issuer |
|
|
All Other
Subsidiaries |
|
|
Eliminations |
|
|
Consolidated |
|
Revenues:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Premiums
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
3,486 |
|
|
$ |
— |
|
|
$ |
3,486 |
|
Net investment income
|
|
|
(1 |
) |
|
|
— |
|
|
|
2,357 |
|
|
|
(11 |
) |
|
|
2,345 |
|
Net investment gains (losses)
|
|
|
— |
|
|
|
— |
|
|
|
(11 |
) |
|
|
— |
|
|
|
(11 |
) |
Insurance and investment product fees and other
|
|
|
— |
|
|
|
(3 |
) |
|
|
684 |
|
|
|
(1 |
) |
|
|
680 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total revenues
|
|
|
(1 |
) |
|
|
(3 |
) |
|
|
6,516 |
|
|
|
(12 |
) |
|
|
6,500 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Benefits and expenses:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Benefits and other changes in policy reserves
|
|
|
— |
|
|
|
— |
|
|
|
4,282 |
|
|
|
— |
|
|
|
4,282 |
|
Interest credited
|
|
|
— |
|
|
|
— |
|
|
|
552 |
|
|
|
— |
|
|
|
552 |
|
Acquisition and operating expenses, net of deferrals
|
|
|
15 |
|
|
|
— |
|
|
|
824 |
|
|
|
— |
|
|
|
839 |
|
Amortization of deferred acquisition costs and intangibles
|
|
|
— |
|
|
|
— |
|
|
|
325 |
|
|
|
— |
|
|
|
325 |
|
Goodwill impairment
|
|
|
— |
|
|
|
— |
|
|
|
550 |
|
|
|
— |
|
|
|
550 |
|
Interest expense
|
|
|
— |
|
|
|
244 |
|
|
|
95 |
|
|
|
(12 |
) |
|
|
327 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total benefits and expenses
|
|
|
15 |
|
|
|
244 |
|
|
|
6,628 |
|
|
|
(12 |
) |
|
|
6,875 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income (loss) from continuing operations before income taxes and
equity in income of subsidiaries
|
|
|
(16 |
) |
|
|
(247 |
) |
|
|
(112 |
) |
|
|
— |
|
|
|
(375 |
) |
Provision (benefit) for income taxes
|
|
|
13 |
|
|
|
(80 |
) |
|
|
55 |
|
|
|
(4 |
) |
|
|
(16 |
) |
Equity in income (loss) of subsidiaries
|
|
|
(455 |
) |
|
|
(389 |
) |
|
|
— |
|
|
|
844 |
|
|
|
— |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income (loss) from continuing operations
|
|
|
(484 |
) |
|
|
(556 |
) |
|
|
(167 |
) |
|
|
848 |
|
|
|
(359 |
) |
Income (loss) from discontinued operations, net of taxes
|
|
|
— |
|
|
|
— |
|
|
|
19 |
|
|
|
— |
|
|
|
19 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income (loss)
|
|
|
(484 |
) |
|
|
(556 |
) |
|
|
(148 |
) |
|
|
848 |
|
|
|
(340 |
) |
Less: net income attributable to noncontrolling interests
|
|
|
— |
|
|
|
— |
|
|
|
144 |
|
|
|
— |
|
|
|
144 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income (loss) available to Genworth Financial, Inc.’s
common stockholders
|
|
$ |
(484 |
) |
|
$ |
(556 |
) |
|
$ |
(292 |
) |
|
$ |
848 |
|
|
$ |
(484 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Condensed Consolidating Statement of Comprehensive Income |
The following table presents the condensed consolidating
comprehensive income statement information for the three months
ended September 30, 2015:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(Amounts in millions)
|
|
Parent
Guarantor |
|
|
Issuer |
|
|
All Other
Subsidiaries |
|
|
Eliminations |
|
|
Consolidated |
|
Net income (loss)
|
|
$ |
(284 |
) |
|
$ |
(358 |
) |
|
$ |
(180 |
) |
|
$ |
584 |
|
|
$ |
(238 |
) |
Other comprehensive income (loss), net of taxes:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net unrealized gains (losses) on securities not
other-than-temporarily impaired
|
|
|
103 |
|
|
|
111 |
|
|
|
85 |
|
|
|
(212 |
) |
|
|
87 |
|
Net unrealized gains (losses) on other-than-temporarily impaired
securities
|
|
|
— |
|
|
|
(1 |
) |
|
|
— |
|
|
|
1 |
|
|
|
— |
|
Derivatives qualifying as hedges
|
|
|
217 |
|
|
|
217 |
|
|
|
231 |
|
|
|
(448 |
) |
|
|
217 |
|
Foreign currency translation and other adjustments
|
|
|
(151 |
) |
|
|
(127 |
) |
|
|
(302 |
) |
|
|
278 |
|
|
|
(302 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total other comprehensive income (loss)
|
|
|
169 |
|
|
|
200 |
|
|
|
14 |
|
|
|
(381 |
) |
|
|
2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total comprehensive income (loss)
|
|
|
(115 |
) |
|
|
(158 |
) |
|
|
(166 |
) |
|
|
203 |
|
|
|
(236 |
) |
Less: comprehensive income attributable to noncontrolling
interests
|
|
|
— |
|
|
|
— |
|
|
|
(121 |
) |
|
|
— |
|
|
|
(121 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total comprehensive income (loss) available to Genworth Financial,
Inc.’s common stockholders
|
|
$ |
(115 |
) |
|
$ |
(158 |
) |
|
$ |
(45 |
) |
|
$ |
203 |
|
|
$ |
(115 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The following table presents the condensed consolidating
comprehensive income statement information for the three months
ended September 30, 2014:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(Amounts in millions)
|
|
Parent
Guarantor |
|
|
Issuer |
|
|
All Other
Subsidiaries |
|
|
Eliminations |
|
|
Consolidated |
|
Net income (loss)
|
|
$ |
(844 |
) |
|
$ |
(837 |
) |
|
$ |
(721 |
) |
|
$ |
1,615 |
|
|
$ |
(787 |
) |
Other comprehensive income (loss), net of taxes:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net unrealized gains (losses) on securities not
other-than-temporarily impaired
|
|
|
(62 |
) |
|
|
(60 |
) |
|
|
(67 |
) |
|
|
121 |
|
|
|
(68 |
) |
Net unrealized gains (losses) on other-than-temporarily impaired
securities
|
|
|
1 |
|
|
|
2 |
|
|
|
1 |
|
|
|
(3 |
) |
|
|
1 |
|
Derivatives qualifying as hedges
|
|
|
101 |
|
|
|
101 |
|
|
|
105 |
|
|
|
(206 |
) |
|
|
101 |
|
Foreign currency translation and other adjustments
|
|
|
(267 |
) |
|
|
(229 |
) |
|
|
(379 |
) |
|
|
496 |
|
|
|
(379 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total other comprehensive income (loss)
|
|
|
(227 |
) |
|
|
(186 |
) |
|
|
(340 |
) |
|
|
408 |
|
|
|
(345 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total comprehensive income (loss)
|
|
|
(1,071 |
) |
|
|
(1,023 |
) |
|
|
(1,061 |
) |
|
|
2,023 |
|
|
|
(1,132 |
) |
Less: comprehensive income attributable to noncontrolling
interests
|
|
|
— |
|
|
|
— |
|
|
|
(61 |
) |
|
|
— |
|
|
|
(61 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total comprehensive income (loss) available to Genworth Financial,
Inc.’s common stockholders
|
|
$ |
(1,071 |
) |
|
$ |
(1,023 |
) |
|
$ |
(1,000 |
) |
|
$ |
2,023 |
|
|
$ |
(1,071 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The following table presents the condensed consolidating
comprehensive income statement information for the nine months
ended September 30, 2015:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(Amounts in millions)
|
|
Parent
Guarantor |
|
|
Issuer |
|
|
All Other
Subsidiaries |
|
|
Eliminations |
|
|
Consolidated |
|
Net income (loss)
|
|
$ |
(323 |
) |
|
$ |
(463 |
) |
|
$ |
(5 |
) |
|
$ |
618 |
|
|
$ |
(173 |
) |
Other comprehensive income (loss), net of taxes:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net unrealized gains (losses) on securities not
other-than-temporarily impaired
|
|
|
(708 |
) |
|
|
(696 |
) |
|
|
(729 |
) |
|
|
1,405 |
|
|
|
(728 |
) |
Net unrealized gains (losses) on other-than-temporarily impaired
securities
|
|
|
— |
|
|
|
(1 |
) |
|
|
— |
|
|
|
1 |
|
|
|
— |
|
Derivatives qualifying as hedges
|
|
|
60 |
|
|
|
60 |
|
|
|
68 |
|
|
|
(128 |
) |
|
|
60 |
|
Foreign currency translation and other adjustments
|
|
|
(344 |
) |
|
|
(276 |
) |
|
|
(619 |
) |
|
|
620 |
|
|
|
(619 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total other comprehensive income (loss)
|
|
|
(992 |
) |
|
|
(913 |
) |
|
|
(1,280 |
) |
|
|
1,898 |
|
|
|
(1,287 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total comprehensive income (loss)
|
|
|
(1,315 |
) |
|
|
(1,376 |
) |
|
|
(1,285 |
) |
|
|
2,516 |
|
|
|
(1,460 |
) |
Less: comprehensive income attributable to noncontrolling
interests
|
|
|
— |
|
|
|
— |
|
|
|
(145 |
) |
|
|
— |
|
|
|
(145 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total comprehensive income (loss) available to Genworth Financial,
Inc.’s common stockholders
|
|
$ |
(1,315 |
) |
|
$ |
(1,376 |
) |
|
$ |
(1,140 |
) |
|
$ |
2,516 |
|
|
$ |
(1,315 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The following table presents the condensed consolidating
comprehensive income statement information for the nine months
ended September 30, 2014:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(Amounts in millions)
|
|
Parent
Guarantor |
|
|
Issuer |
|
|
All Other
Subsidiaries |
|
|
Eliminations |
|
|
Consolidated |
|
Net income (loss)
|
|
$ |
(484 |
) |
|
$ |
(556 |
) |
|
$ |
(148 |
) |
|
$ |
848 |
|
|
$ |
(340 |
) |
Other comprehensive income (loss), net of taxes:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net unrealized gains (losses) on securities not
other-than-temporarily impaired
|
|
|
1,155 |
|
|
|
1,129 |
|
|
|
1,171 |
|
|
|
(2,284 |
) |
|
|
1,171 |
|
Net unrealized gains (losses) on other-than-temporarily impaired
securities
|
|
|
8 |
|
|
|
9 |
|
|
|
8 |
|
|
|
(17 |
) |
|
|
8 |
|
Derivatives qualifying as hedges
|
|
|
434 |
|
|
|
434 |
|
|
|
460 |
|
|
|
(894 |
) |
|
|
434 |
|
Foreign currency translation and other adjustments
|
|
|
(148 |
) |
|
|
(109 |
) |
|
|
(252 |
) |
|
|
257 |
|
|
|
(252 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total other comprehensive income (loss)
|
|
|
1,449 |
|
|
|
1,463 |
|
|
|
1,387 |
|
|
|
(2,938 |
) |
|
|
1,361 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total comprehensive income (loss)
|
|
|
965 |
|
|
|
907 |
|
|
|
1,239 |
|
|
|
(2,090 |
) |
|
|
1,021 |
|
Less: comprehensive income attributable to noncontrolling
interests
|
|
|
— |
|
|
|
— |
|
|
|
56 |
|
|
|
— |
|
|
|
56 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total comprehensive income (loss) available to Genworth Financial,
Inc.’s common stockholders
|
|
$ |
965 |
|
|
$ |
907 |
|
|
$ |
1,183 |
|
|
$ |
(2,090 |
) |
|
$ |
965 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Condensed Consolidating Statement of Cash Flows |
The following table presents the condensed consolidating cash flow
statement information for the nine months ended September 30,
2015:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(Amounts in millions)
|
|
Parent
Guarantor |
|
|
Issuer |
|
|
All Other
Subsidiaries |
|
|
Eliminations |
|
|
Consolidated |
|
Cash flows from operating activities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income (loss)
|
|
$ |
(323 |
) |
|
$ |
(463 |
) |
|
$ |
(5 |
) |
|
$ |
618 |
|
|
$ |
(173 |
) |
Less loss from discontinued operations, net of taxes
|
|
|
6 |
|
|
|
— |
|
|
|
328 |
|
|
|
— |
|
|
|
334 |
|
Adjustments to reconcile net income (loss) to net cash from
operating activities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Equity in (income) loss from subsidiaries
|
|
|
299 |
|
|
|
319 |
|
|
|
— |
|
|
|
(618 |
) |
|
|
— |
|
Dividends from subsidiaries
|
|
|
— |
|
|
|
454 |
|
|
|
(454 |
) |
|
|
— |
|
|
|
— |
|
Amortization of fixed maturity securities discounts and premiums
and limited partnerships
|
|
|
— |
|
|
|
— |
|
|
|
(80 |
) |
|
|
— |
|
|
|
(80 |
) |
Net investment losses (gains)
|
|
|
— |
|
|
|
(37 |
) |
|
|
96 |
|
|
|
— |
|
|
|
59 |
|
Charges assessed to policyholders
|
|
|
— |
|
|
|
— |
|
|
|
(586 |
) |
|
|
— |
|
|
|
(586 |
) |
Acquisition costs deferred
|
|
|
— |
|
|
|
— |
|
|
|
(226 |
) |
|
|
— |
|
|
|
(226 |
) |
Amortization of deferred acquisition costs and intangibles
|
|
|
— |
|
|
|
— |
|
|
|
759 |
|
|
|
— |
|
|
|
759 |
|
Deferred income taxes
|
|
|
(2 |
) |
|
|
(102 |
) |
|
|
(13 |
) |
|
|
— |
|
|
|
(117 |
) |
Net increase (decrease) in trading securities, held-for-sale
investments and derivative instruments
|
|
|
— |
|
|
|
27 |
|
|
|
(274 |
) |
|
|
— |
|
|
|
(247 |
) |
Stock-based compensation expense
|
|
|
16 |
|
|
|
— |
|
|
|
(2 |
) |
|
|
— |
|
|
|
14 |
|
Change in certain assets and liabilities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accrued investment income and other assets
|
|
|
— |
|
|
|
3 |
|
|
|
(133 |
) |
|
|
(3 |
) |
|
|
(133 |
) |
Insurance reserves
|
|
|
— |
|
|
|
— |
|
|
|
1,270 |
|
|
|
— |
|
|
|
1,270 |
|
Current tax liabilities
|
|
|
(1 |
) |
|
|
13 |
|
|
|
(88 |
) |
|
|
5 |
|
|
|
(71 |
) |
Other liabilities, policy and contract claims and other
policy-related balances
|
|
|
— |
|
|
|
(1 |
) |
|
|
353 |
|
|
|
— |
|
|
|
352 |
|
Cash from operating activities—discontinued operations
|
|
|
— |
|
|
|
— |
|
|
|
3 |
|
|
|
— |
|
|
|
3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash from operating activities
|
|
|
(5 |
) |
|
|
213 |
|
|
|
948 |
|
|
|
2 |
|
|
|
1,158 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash flows from investing activities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Proceeds from maturities and repayments of investments:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fixed maturity securities
|
|
|
— |
|
|
|
1 |
|
|
|
3,388 |
|
|
|
— |
|
|
|
3,389 |
|
Commercial mortgage loans
|
|
|
— |
|
|
|
— |
|
|
|
640 |
|
|
|
— |
|
|
|
640 |
|
Restricted commercial mortgage loans related to securitization
entities
|
|
|
— |
|
|
|
— |
|
|
|
27 |
|
|
|
— |
|
|
|
27 |
|
Proceeds from sales of investments:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fixed maturity and equity securities
|
|
|
— |
|
|
|
— |
|
|
|
1,333 |
|
|
|
— |
|
|
|
1,333 |
|
Purchases and originations of investments:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fixed maturity and equity securities
|
|
|
— |
|
|
|
— |
|
|
|
(6,836 |
) |
|
|
— |
|
|
|
(6,836 |
) |
Commercial mortgage loans
|
|
|
— |
|
|
|
— |
|
|
|
(678 |
) |
|
|
— |
|
|
|
(678 |
) |
Other invested assets, net
|
|
|
— |
|
|
|
(100 |
) |
|
|
63 |
|
|
|
(2 |
) |
|
|
(39 |
) |
Policy loans, net
|
|
|
— |
|
|
|
— |
|
|
|
23 |
|
|
|
— |
|
|
|
23 |
|
Intercompany notes receivable
|
|
|
7 |
|
|
|
(24 |
) |
|
|
(4 |
) |
|
|
21 |
|
|
|
— |
|
Capital contributions to subsidiaries
|
|
|
— |
|
|
|
(25 |
) |
|
|
25 |
|
|
|
— |
|
|
|
— |
|
Cash transferred for purchase of a subsidiary
|
|
|
— |
|
|
|
(202 |
) |
|
|
202 |
|
|
|
— |
|
|
|
— |
|
Cash from investing activities—discontinued operations
|
|
|
— |
|
|
|
— |
|
|
|
(22 |
) |
|
|
— |
|
|
|
(22 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash from investing activities
|
|
|
7 |
|
|
|
(350 |
) |
|
|
(1,839 |
) |
|
|
19 |
|
|
|
(2,163 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash flows from financing activities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Deposits to universal life and investment contracts
|
|
|
— |
|
|
|
— |
|
|
|
1,693 |
|
|
|
— |
|
|
|
1,693 |
|
Withdrawals from universal life and investment contracts
|
|
|
— |
|
|
|
— |
|
|
|
(1,677 |
) |
|
|
— |
|
|
|
(1,677 |
) |
Redemption of non-recourse funding obligations
|
|
|
— |
|
|
|
— |
|
|
|
(45 |
) |
|
|
— |
|
|
|
(45 |
) |
Proceeds from the issuance of long-term debt
|
|
|
— |
|
|
|
— |
|
|
|
150 |
|
|
|
— |
|
|
|
150 |
|
Repayment and repurchase of long-term debt
|
|
|
— |
|
|
|
(50 |
) |
|
|
(70 |
) |
|
|
— |
|
|
|
(120 |
) |
Repayment of borrowings related to securitization entities
|
|
|
— |
|
|
|
— |
|
|
|
(26 |
) |
|
|
— |
|
|
|
(26 |
) |
Proceeds from sale of subsidiary shares to noncontrolling
interests
|
|
|
— |
|
|
|
— |
|
|
|
226 |
|
|
|
— |
|
|
|
226 |
|
Repurchase of subsidiary shares
|
|
|
— |
|
|
|
— |
|
|
|
(17 |
) |
|
|
— |
|
|
|
(17 |
) |
Dividends paid to noncontrolling interests
|
|
|
— |
|
|
|
— |
|
|
|
(145 |
) |
|
|
— |
|
|
|
(145 |
) |
Proceeds from intercompany notes payable
|
|
|
— |
|
|
|
(2 |
) |
|
|
23 |
|
|
|
(21 |
) |
|
|
— |
|
Other, net
|
|
|
(2 |
) |
|
|
(30 |
) |
|
|
7 |
|
|
|
— |
|
|
|
(25 |
) |
Cash from financing activities—discontinued operations
|
|
|
— |
|
|
|
— |
|
|
|
(33 |
) |
|
|
— |
|
|
|
(33 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash from financing activities
|
|
|
(2 |
) |
|
|
(82 |
) |
|
|
86 |
|
|
|
(21 |
) |
|
|
(19 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Effect of exchange rate changes on cash and cash equivalents
|
|
|
— |
|
|
|
— |
|
|
|
(86 |
) |
|
|
— |
|
|
|
(86 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net change in cash and cash equivalents
|
|
|
— |
|
|
|
(219 |
) |
|
|
(891 |
) |
|
|
— |
|
|
|
(1,110 |
) |
Cash and cash equivalents at beginning of period
|
|
|
— |
|
|
|
953 |
|
|
|
3,965 |
|
|
|
— |
|
|
|
4,918 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash and cash equivalents at end of period
|
|
|
— |
|
|
|
734 |
|
|
|
3,074 |
|
|
|
— |
|
|
|
3,808 |
|
Less cash and cash equivalents of discontinued operations at end of
period
|
|
|
— |
|
|
|
— |
|
|
|
142 |
|
|
|
— |
|
|
|
142 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash and cash equivalents of continuing operations at end of
period
|
|
$ |
— |
|
|
$ |
734 |
|
|
$ |
2,932 |
|
|
$ |
— |
|
|
$ |
3,666 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The following table presents the condensed consolidating cash flow
statement information for the nine months ended September 30,
2014:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(Amounts in millions)
|
|
Parent
Guarantor |
|
|
Issuer |
|
|
All Other
Subsidiaries |
|
|
Eliminations |
|
|
Consolidated |
|
Cash flows from operating activities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income (loss)
|
|
$ |
(484 |
) |
|
$ |
(556 |
) |
|
$ |
(148 |
) |
|
$ |
848 |
|
|
$ |
(340 |
) |
Less income from discontinued operations, net of taxes
|
|
|
— |
|
|
|
— |
|
|
|
(19 |
) |
|
|
— |
|
|
|
(19 |
) |
Adjustments to reconcile net income (loss) to net cash from
operating activities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Equity in (income) loss from subsidiaries
|
|
|
455 |
|
|
|
389 |
|
|
|
— |
|
|
|
(844 |
) |
|
|
— |
|
Dividends from subsidiaries
|
|
|
— |
|
|
|
563 |
|
|
|
(563 |
) |
|
|
— |
|
|
|
— |
|
Amortization of fixed maturity securities discounts and premiums
and limited partnerships
|
|
|
— |
|
|
|
— |
|
|
|
(97 |
) |
|
|
— |
|
|
|
(97 |
) |
Net investment losses (gains)
|
|
|
— |
|
|
|
— |
|
|
|
11 |
|
|
|
— |
|
|
|
11 |
|
Charges assessed to policyholders
|
|
|
— |
|
|
|
— |
|
|
|
(580 |
) |
|
|
— |
|
|
|
(580 |
) |
Acquisition costs deferred
|
|
|
— |
|
|
|
— |
|
|
|
(282 |
) |
|
|
— |
|
|
|
(282 |
) |
Amortization of deferred acquisition costs and intangibles
|
|
|
— |
|
|
|
— |
|
|
|
325 |
|
|
|
— |
|
|
|
325 |
|
Goodwill impairment
|
|
|
— |
|
|
|
— |
|
|
|
550 |
|
|
|
— |
|
|
|
550 |
|
Deferred income taxes
|
|
|
25 |
|
|
|
(137 |
) |
|
|
(70 |
) |
|
|
(4 |
) |
|
|
(186 |
) |
Net increase (decrease) in trading securities, held-for-sale
investments and derivative instruments
|
|
|
— |
|
|
|
— |
|
|
|
110 |
|
|
|
— |
|
|
|
110 |
|
Stock-based compensation expense
|
|
|
15 |
|
|
|
— |
|
|
|
4 |
|
|
|
— |
|
|
|
19 |
|
Change in certain assets and liabilities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accrued investment income and other assets
|
|
|
(2 |
) |
|
|
44 |
|
|
|
(213 |
) |
|
|
(4 |
) |
|
|
(175 |
) |
Insurance reserves
|
|
|
— |
|
|
|
— |
|
|
|
1,260 |
|
|
|
— |
|
|
|
1,260 |
|
Current tax liabilities
|
|
|
(16 |
) |
|
|
(37 |
) |
|
|
(132 |
) |
|
|
— |
|
|
|
(185 |
) |
Other liabilities, policy and contract claims and other
policy-related balances
|
|
|
12 |
|
|
|
51 |
|
|
|
665 |
|
|
|
3 |
|
|
|
731 |
|
Cash from operating activities—discontinued operations
|
|
|
— |
|
|
|
— |
|
|
|
(2 |
) |
|
|
— |
|
|
|
(2 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash from operating activities
|
|
|
5 |
|
|
|
317 |
|
|
|
819 |
|
|
|
(1 |
) |
|
|
1,140 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash flows from investing activities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Proceeds from maturities and repayments of investments:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fixed maturity securities
|
|
|
— |
|
|
|
— |
|
|
|
3,638 |
|
|
|
— |
|
|
|
3,638 |
|
Commercial mortgage loans
|
|
|
— |
|
|
|
— |
|
|
|
528 |
|
|
|
— |
|
|
|
528 |
|
Restricted commercial mortgage loans related to securitization
entities
|
|
|
— |
|
|
|
— |
|
|
|
24 |
|
|
|
— |
|
|
|
24 |
|
Proceeds from sales of investments:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fixed maturity and equity securities
|
|
|
— |
|
|
|
— |
|
|
|
1,651 |
|
|
|
— |
|
|
|
1,651 |
|
Purchases and originations of investments:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fixed maturity and equity securities
|
|
|
— |
|
|
|
— |
|
|
|
(7,202 |
) |
|
|
— |
|
|
|
(7,202 |
) |
Commercial mortgage loans
|
|
|
— |
|
|
|
— |
|
|
|
(709 |
) |
|
|
— |
|
|
|
(709 |
) |
Other invested assets, net
|
|
|
— |
|
|
|
— |
|
|
|
103 |
|
|
|
1 |
|
|
|
104 |
|
Policy loans, net
|
|
|
— |
|
|
|
— |
|
|
|
11 |
|
|
|
— |
|
|
|
11 |
|
Intercompany notes receivable
|
|
|
8 |
|
|
|
(15 |
) |
|
|
9 |
|
|
|
(2 |
) |
|
|
— |
|
Capital contributions to subsidiaries
|
|
|
(12 |
) |
|
|
— |
|
|
|
12 |
|
|
|
— |
|
|
|
— |
|
Cash from investing activities—discontinued operations
|
|
|
— |
|
|
|
|
|
|
|
(48 |
) |
|
|
— |
|
|
|
(48 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash from investing activities
|
|
|
(4 |
) |
|
|
(15 |
) |
|
|
(1,983 |
) |
|
|
(1 |
) |
|
|
(2,003 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash flows from financing activities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Deposits to universal life and investment contracts
|
|
|
— |
|
|
|
— |
|
|
|
2,201 |
|
|
|
— |
|
|
|
2,201 |
|
Withdrawals from universal life and investment contracts
|
|
|
— |
|
|
|
— |
|
|
|
(1,950 |
) |
|
|
— |
|
|
|
(1,950 |
) |
Redemption of non-recourse funding obligations
|
|
|
— |
|
|
|
— |
|
|
|
(28 |
) |
|
|
— |
|
|
|
(28 |
) |
Proceeds from the issuance of long-term debt
|
|
|
— |
|
|
|
— |
|
|
|
144 |
|
|
|
— |
|
|
|
144 |
|
Repayment and repurchase of long-term debt
|
|
|
— |
|
|
|
(485 |
) |
|
|
(136 |
) |
|
|
— |
|
|
|
(621 |
) |
Repayment of borrowings related to securitization entities
|
|
|
— |
|
|
|
— |
|
|
|
(24 |
) |
|
|
— |
|
|
|
(24 |
) |
Proceeds from sale of subsidiary shares to noncontrolling
interests
|
|
|
— |
|
|
|
— |
|
|
|
517 |
|
|
|
— |
|
|
|
517 |
|
Dividends paid to noncontrolling interests
|
|
|
— |
|
|
|
— |
|
|
|
(46 |
) |
|
|
— |
|
|
|
(46 |
) |
Proceeds from intercompany notes payable
|
|
|
1 |
|
|
|
(17 |
) |
|
|
14 |
|
|
|
2 |
|
|
|
— |
|
Other, net
|
|
|
(2 |
) |
|
|
(31 |
) |
|
|
14 |
|
|
|
— |
|
|
|
(19 |
) |
Cash from financing activities—discontinued operations
|
|
|
— |
|
|
|
— |
|
|
|
(25 |
) |
|
|
— |
|
|
|
(25 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash from financing activities
|
|
|
(1 |
) |
|
|
(533 |
) |
|
|
681 |
|
|
|
2 |
|
|
|
149 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Effect of exchange rate changes on cash and cash equivalents
|
|
|
— |
|
|
|
— |
|
|
|
(23 |
) |
|
|
— |
|
|
|
(23 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net change in cash and cash equivalents
|
|
|
— |
|
|
|
(231 |
) |
|
|
(506 |
) |
|
|
— |
|
|
|
(737 |
) |
Cash and cash equivalents at beginning of period
|
|
|
— |
|
|
|
1,219 |
|
|
|
2,995 |
|
|
|
— |
|
|
|
4,214 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash and cash equivalents at end of period
|
|
|
— |
|
|
|
988 |
|
|
|
2,489 |
|
|
|
— |
|
|
|
3,477 |
|
Less cash and cash equivalents of discontinued operations at end of
period
|
|
|
— |
|
|
|
— |
|
|
|
193 |
|
|
|
— |
|
|
|
193 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash and cash equivalents from continuing operations at end of
period
|
|
$ |
— |
|
|
$ |
988 |
|
|
$ |
2,296 |
|
|
$ |
— |
|
|
$ |
3,284 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|